Randomized Phase II Study of Pemetrexed Versus Gefitinib in Previously Treated Patients with Advanced Non-small Cell Lung Cancer

PURPOSE: This study aimed to evaluate the efficacy and safety of pemetrexed versus gefitinib in patients with advanced non-small cell lung cancer (NSCLC) previously treated with chemotherapy. MATERIALS AND METHODS: Patients with advanced (stage IIIB or IV) or recurrent NSCLC were randomly assigned t...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Cancer Res Treat
Autori principali: Kim, Young Saing, Cho, Eun Kyung, Woo, Hyun Sun, Hong, Junshik, Ahn, Hee Kyung, Park, Inkeun, Sym, Sun Jin, Kyung, Sun Young, Kang, Shin Myung, Park, Jeong-Woong, Jeong, Sung Hwan, Park, Jinny, Lee, Jae Hoon, Shin, Dong Bok
Natura: Artigo
Lingua:Inglês
Pubblicazione: Korean Cancer Association 2016
Soggetti:
Original Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC4720098/
https://ncbi.nlm.nih.gov/pubmed/25761488
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4143/crt.2014.307
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi